nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproterone acetate—CYP19A1—Tamoxifen—pancreatic cancer	0.399	1	CbGbCtD
Cyproterone acetate—AR—Nuclear Receptor transcription pathway—NR5A2—pancreatic cancer	0.0032	0.0259	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptors—NR5A2—pancreatic cancer	0.00307	0.0248	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—BACH1—pancreatic cancer	0.00292	0.0237	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—BACH1—pancreatic cancer	0.00251	0.0204	CbGpPWpGaD
Cyproterone acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—PDX1—pancreatic cancer	0.00247	0.02	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptor transcription pathway—NR5A2—pancreatic cancer	0.00243	0.0196	CbGpPWpGaD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—HEY2—pancreatic cancer	0.00242	0.0196	CbGpPWpGaD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—HEY1—pancreatic cancer	0.00224	0.0182	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—GDI1—pancreatic cancer	0.00221	0.0179	CbGpPWpGaD
Cyproterone acetate—AR—FOXA1 transcription factor network—SHH—pancreatic cancer	0.00197	0.016	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—GDI1—pancreatic cancer	0.00191	0.0154	CbGpPWpGaD
Cyproterone acetate—NR3C1—Endoderm Differentiation—DAB2—pancreatic cancer	0.00183	0.0148	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—DAXX—pancreatic cancer	0.00178	0.0144	CbGpPWpGaD
Cyproterone acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—SLC2A2—pancreatic cancer	0.00156	0.0126	CbGpPWpGaD
Cyproterone acetate—AR—FOXA1 transcription factor network—GCG—pancreatic cancer	0.00152	0.0123	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TFF1—pancreatic cancer	0.00133	0.0107	CbGpPWpGaD
Cyproterone acetate—CYP19A1—FSH signaling pathway—TSC2—pancreatic cancer	0.0013	0.0105	CbGpPWpGaD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—HES1—pancreatic cancer	0.00116	0.00941	CbGpPWpGaD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—PPARG—pancreatic cancer	0.00115	0.00933	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—SSTR1—pancreatic cancer	0.00113	0.00917	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—SSTR2—pancreatic cancer	0.00109	0.00883	CbGpPWpGaD
Cyproterone acetate—NR3C1—Endoderm Differentiation—PTHLH—pancreatic cancer	0.001	0.0081	CbGpPWpGaD
Cyproterone acetate—AR—Nuclear Receptors—PPARG—pancreatic cancer	0.000981	0.00794	CbGpPWpGaD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—HIF1A—pancreatic cancer	0.000974	0.00788	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—DAXX—pancreatic cancer	0.000964	0.0078	CbGpPWpGaD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—KDR—pancreatic cancer	0.000931	0.00754	CbGpPWpGaD
Cyproterone acetate—NR3C1—Endoderm Differentiation—EZH2—pancreatic cancer	0.000911	0.00738	CbGpPWpGaD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—NOTCH1—pancreatic cancer	0.000877	0.0071	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—SSTR1—pancreatic cancer	0.00086	0.00696	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—FOXM1—pancreatic cancer	0.000859	0.00695	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—AHR—pancreatic cancer	0.000841	0.00681	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—SSTR2—pancreatic cancer	0.000828	0.0067	CbGpPWpGaD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—RB1—pancreatic cancer	0.000792	0.00641	CbGpPWpGaD
Cyproterone acetate—AR—Nuclear Receptor transcription pathway—PPARG—pancreatic cancer	0.000776	0.00628	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—SMAD4—pancreatic cancer	0.00077	0.00623	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptors—PPARG—pancreatic cancer	0.000745	0.00603	CbGpPWpGaD
Cyproterone acetate—AR—Nongenotropic Androgen signaling—SRC—pancreatic cancer	0.000735	0.00595	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—AHR—pancreatic cancer	0.000724	0.00586	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—AHR—pancreatic cancer	0.000719	0.00582	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—SMAD4—pancreatic cancer	0.000714	0.00578	CbGpPWpGaD
Cyproterone acetate—CYP19A1—FSH signaling pathway—SRC—pancreatic cancer	0.000706	0.00572	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—WT1—pancreatic cancer	0.000679	0.0055	CbGpPWpGaD
Cyproterone acetate—NR3C1—Endoderm Differentiation—SMAD4—pancreatic cancer	0.000672	0.00544	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—pancreatic cancer	0.000665	0.00539	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—FOXM1—pancreatic cancer	0.000652	0.00527	CbGpPWpGaD
Cyproterone acetate—NR3C1—Circadian Clock—HIF1A—pancreatic cancer	0.000651	0.00527	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—GADD45A—pancreatic cancer	0.000624	0.00505	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—SST—pancreatic cancer	0.000621	0.00503	CbGpPWpGaD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—TNF—pancreatic cancer	0.000612	0.00496	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	0.000609	0.00493	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	0.000602	0.00487	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptor transcription pathway—PPARG—pancreatic cancer	0.000588	0.00476	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—SMAD4—pancreatic cancer	0.000584	0.00473	CbGpPWpGaD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—CDKN2A—pancreatic cancer	0.000565	0.00458	CbGpPWpGaD
Cyproterone acetate—AR—Nongenotropic Androgen signaling—PIK3CA—pancreatic cancer	0.000559	0.00453	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—NR5A2—pancreatic cancer	0.000552	0.00447	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—HIF1A—pancreatic cancer	0.000537	0.00435	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—GADD45A—pancreatic cancer	0.000537	0.00434	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—STK11—pancreatic cancer	0.000534	0.00432	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—GADD45A—pancreatic cancer	0.000533	0.00432	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—PLAU—pancreatic cancer	0.000532	0.00431	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	0.000526	0.00426	CbGpPWpGaD
Cyproterone acetate—AR—Nongenotropic Androgen signaling—HRAS—pancreatic cancer	0.000517	0.00419	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	0.000517	0.00418	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—pancreatic cancer	0.000516	0.00418	CbGpPWpGaD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—STAT3—pancreatic cancer	0.000508	0.00411	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—pancreatic cancer	0.000497	0.00402	CbGpPWpGaD
Cyproterone acetate—NR3C1—Endoderm Differentiation—NOTCH1—pancreatic cancer	0.000495	0.00401	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—BRCA2—pancreatic cancer	0.000483	0.00391	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of Androgen receptor activity—SRC—pancreatic cancer	0.000479	0.00387	CbGpPWpGaD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—CCND1—pancreatic cancer	0.000478	0.00387	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—RB1—pancreatic cancer	0.000475	0.00385	CbGpPWpGaD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—CTNNB1—pancreatic cancer	0.000473	0.00383	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—SST—pancreatic cancer	0.000471	0.00381	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—SMAD4—pancreatic cancer	0.000468	0.00379	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—STK11—pancreatic cancer	0.00046	0.00372	CbGpPWpGaD
Cyproterone acetate—AR—Nongenotropic Androgen signaling—AKT1—pancreatic cancer	0.000457	0.0037	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—pancreatic cancer	0.000455	0.00368	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—HES1—pancreatic cancer	0.000445	0.0036	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	0.000443	0.00358	CbGpPWpGaD
Cyproterone acetate—CYP19A1—FSH signaling pathway—AKT1—pancreatic cancer	0.000439	0.00355	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—NR5A2—pancreatic cancer	0.000419	0.00339	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—BRCA2—pancreatic cancer	0.000416	0.00336	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—pancreatic cancer	0.000413	0.00334	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—SMAD4—pancreatic cancer	0.000403	0.00326	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	0.0004	0.00324	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	0.000388	0.00314	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—pancreatic cancer	0.000385	0.00311	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CDKN2A—pancreatic cancer	0.000384	0.00311	CbGpPWpGaD
Cyproterone acetate—Angiopathy—Docetaxel—pancreatic cancer	0.000384	0.000803	CcSEcCtD
Cyproterone acetate—Dyspepsia—Irinotecan—pancreatic cancer	0.000383	0.000801	CcSEcCtD
Cyproterone acetate—Immune system disorder—Docetaxel—pancreatic cancer	0.000382	0.0008	CcSEcCtD
Cyproterone acetate—Headache—Erlotinib—pancreatic cancer	0.000382	0.000799	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—TSC2—pancreatic cancer	0.000382	0.00309	CbGpPWpGaD
Cyproterone acetate—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000381	0.000798	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—pancreatic cancer	0.000381	0.00308	CbGpPWpGaD
Cyproterone acetate—Liver function test abnormal—Epirubicin—pancreatic cancer	0.000381	0.000797	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	0.000381	0.00308	CbGpPWpGaD
Cyproterone acetate—Chills—Docetaxel—pancreatic cancer	0.00038	0.000794	CcSEcCtD
Cyproterone acetate—Asthenia—Sunitinib—pancreatic cancer	0.000379	0.000793	CcSEcCtD
Cyproterone acetate—Decreased appetite—Irinotecan—pancreatic cancer	0.000378	0.000791	CcSEcCtD
Cyproterone acetate—Dyspnoea—Gemcitabine—pancreatic cancer	0.000378	0.00079	CcSEcCtD
Cyproterone acetate—Migraine—Doxorubicin—pancreatic cancer	0.000376	0.000786	CcSEcCtD
Cyproterone acetate—Affect lability—Doxorubicin—pancreatic cancer	0.000376	0.000786	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000375	0.000786	CcSEcCtD
Cyproterone acetate—Fatigue—Irinotecan—pancreatic cancer	0.000375	0.000785	CcSEcCtD
Cyproterone acetate—Alopecia—Docetaxel—pancreatic cancer	0.000374	0.000782	CcSEcCtD
Cyproterone acetate—Pruritus—Sunitinib—pancreatic cancer	0.000373	0.000782	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—pancreatic cancer	0.000373	0.00302	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—HIF1A—pancreatic cancer	0.000373	0.00302	CbGpPWpGaD
Cyproterone acetate—Breast disorder—Epirubicin—pancreatic cancer	0.000373	0.00078	CcSEcCtD
Cyproterone acetate—Constipation—Irinotecan—pancreatic cancer	0.000372	0.000778	CcSEcCtD
Cyproterone acetate—Aspartate aminotransferase increased—Epirubicin—pancreatic cancer	0.000371	0.000777	CcSEcCtD
Cyproterone acetate—Dyspnoea—Fluorouracil—pancreatic cancer	0.000371	0.000777	CcSEcCtD
Cyproterone acetate—Mental disorder—Docetaxel—pancreatic cancer	0.000371	0.000776	CcSEcCtD
Cyproterone acetate—Malnutrition—Docetaxel—pancreatic cancer	0.000368	0.000771	CcSEcCtD
Cyproterone acetate—Decreased appetite—Gemcitabine—pancreatic cancer	0.000368	0.000771	CcSEcCtD
Cyproterone acetate—Dyspepsia—Fluorouracil—pancreatic cancer	0.000367	0.000767	CcSEcCtD
Cyproterone acetate—Nausea—Tamoxifen—pancreatic cancer	0.000366	0.000766	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000366	0.000765	CcSEcCtD
Cyproterone acetate—Fatigue—Gemcitabine—pancreatic cancer	0.000365	0.000764	CcSEcCtD
Cyproterone acetate—Muscular weakness—Epirubicin—pancreatic cancer	0.000364	0.000761	CcSEcCtD
Cyproterone acetate—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	0.000364	0.000761	CcSEcCtD
Cyproterone acetate—NR3C1—Regulation of Androgen receptor activity—SRC—pancreatic cancer	0.000363	0.00294	CbGpPWpGaD
Cyproterone acetate—Constipation—Gemcitabine—pancreatic cancer	0.000362	0.000758	CcSEcCtD
Cyproterone acetate—Nausea—Erlotinib—pancreatic cancer	0.000362	0.000758	CcSEcCtD
Cyproterone acetate—Decreased appetite—Fluorouracil—pancreatic cancer	0.000362	0.000758	CcSEcCtD
Cyproterone acetate—Mood swings—Doxorubicin—pancreatic cancer	0.000362	0.000757	CcSEcCtD
Cyproterone acetate—Diarrhoea—Sunitinib—pancreatic cancer	0.000361	0.000756	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.00036	0.000752	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Irinotecan—pancreatic cancer	0.000358	0.00075	CcSEcCtD
Cyproterone acetate—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.000358	0.000748	CcSEcCtD
Cyproterone acetate—Asthma—Epirubicin—pancreatic cancer	0.000356	0.000746	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000356	0.000744	CcSEcCtD
Cyproterone acetate—AR—Androgen receptor signaling pathway—CCND1—pancreatic cancer	0.000353	0.00286	CbGpPWpGaD
Cyproterone acetate—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.000352	0.000737	CcSEcCtD
Cyproterone acetate—AR—Androgen receptor signaling pathway—CTNNB1—pancreatic cancer	0.00035	0.00283	CbGpPWpGaD
Cyproterone acetate—Pancreatitis—Epirubicin—pancreatic cancer	0.00035	0.000732	CcSEcCtD
Cyproterone acetate—Dizziness—Sunitinib—pancreatic cancer	0.000349	0.000731	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000349	0.00073	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CXCL8—pancreatic cancer	0.000348	0.00282	CbGpPWpGaD
Cyproterone acetate—Breast disorder—Doxorubicin—pancreatic cancer	0.000345	0.000722	CcSEcCtD
Cyproterone acetate—Abdominal pain—Irinotecan—pancreatic cancer	0.000344	0.000719	CcSEcCtD
Cyproterone acetate—Body temperature increased—Irinotecan—pancreatic cancer	0.000344	0.000719	CcSEcCtD
Cyproterone acetate—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.000344	0.000719	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000343	0.000718	CcSEcCtD
Cyproterone acetate—AR—Androgen receptor signaling pathway—PTEN—pancreatic cancer	0.000341	0.00276	CbGpPWpGaD
Cyproterone acetate—Anaemia—Docetaxel—pancreatic cancer	0.00034	0.000712	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—HES1—pancreatic cancer	0.000338	0.00273	CbGpPWpGaD
Cyproterone acetate—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.000337	0.000704	CcSEcCtD
Cyproterone acetate—Muscular weakness—Doxorubicin—pancreatic cancer	0.000337	0.000704	CcSEcCtD
Cyproterone acetate—Vomiting—Sunitinib—pancreatic cancer	0.000336	0.000702	CcSEcCtD
Cyproterone acetate—Body temperature increased—Gemcitabine—pancreatic cancer	0.000335	0.000701	CcSEcCtD
Cyproterone acetate—Rash—Sunitinib—pancreatic cancer	0.000333	0.000697	CcSEcCtD
Cyproterone acetate—Dermatitis—Sunitinib—pancreatic cancer	0.000332	0.000696	CcSEcCtD
Cyproterone acetate—Urticaria—Fluorouracil—pancreatic cancer	0.000331	0.000692	CcSEcCtD
Cyproterone acetate—Headache—Sunitinib—pancreatic cancer	0.000331	0.000692	CcSEcCtD
Cyproterone acetate—Syncope—Docetaxel—pancreatic cancer	0.00033	0.000691	CcSEcCtD
Cyproterone acetate—Asthma—Doxorubicin—pancreatic cancer	0.00033	0.00069	CcSEcCtD
Cyproterone acetate—Leukopenia—Docetaxel—pancreatic cancer	0.00033	0.00069	CcSEcCtD
Cyproterone acetate—Pollakiuria—Epirubicin—pancreatic cancer	0.000329	0.000689	CcSEcCtD
Cyproterone acetate—Body temperature increased—Fluorouracil—pancreatic cancer	0.000329	0.000689	CcSEcCtD
Cyproterone acetate—NR3C1—Endoderm Differentiation—CTNNB1—pancreatic cancer	0.000329	0.00266	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—TSC2—pancreatic cancer	0.000329	0.00266	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—HIF1A—pancreatic cancer	0.000327	0.00265	CbGpPWpGaD
Cyproterone acetate—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000325	0.000681	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CCND1—pancreatic cancer	0.000325	0.00263	CbGpPWpGaD
Cyproterone acetate—Weight increased—Epirubicin—pancreatic cancer	0.000324	0.000679	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Docetaxel—pancreatic cancer	0.000324	0.000677	CcSEcCtD
Cyproterone acetate—Pancreatitis—Doxorubicin—pancreatic cancer	0.000323	0.000677	CcSEcCtD
Cyproterone acetate—Weight decreased—Epirubicin—pancreatic cancer	0.000323	0.000675	CcSEcCtD
Cyproterone acetate—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000322	0.000673	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CTNNB1—pancreatic cancer	0.000321	0.0026	CbGpPWpGaD
Cyproterone acetate—Cough—Docetaxel—pancreatic cancer	0.000321	0.000673	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Irinotecan—pancreatic cancer	0.00032	0.00067	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—CHD3—pancreatic cancer	0.000317	0.00257	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—MEN1—pancreatic cancer	0.000317	0.00257	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—SRC—pancreatic cancer	0.000316	0.00256	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—MMP9—pancreatic cancer	0.000315	0.00255	CbGpPWpGaD
Cyproterone acetate—Nausea—Sunitinib—pancreatic cancer	0.000314	0.000656	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—PTEN—pancreatic cancer	0.000313	0.00254	CbGpPWpGaD
Cyproterone acetate—Renal failure—Epirubicin—pancreatic cancer	0.000312	0.000654	CcSEcCtD
Cyproterone acetate—Asthenia—Irinotecan—pancreatic cancer	0.000312	0.000653	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—RB1—pancreatic cancer	0.000312	0.00252	CbGpPWpGaD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000311	0.000652	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CDH1—pancreatic cancer	0.00031	0.00251	CbGpPWpGaD
Cyproterone acetate—Jaundice—Epirubicin—pancreatic cancer	0.00031	0.000648	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—pancreatic cancer	0.000308	0.0025	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—pancreatic cancer	0.000307	0.00249	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000307	0.000642	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—MYC—pancreatic cancer	0.000305	0.00247	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—STAT3—pancreatic cancer	0.000305	0.00247	CbGpPWpGaD
Cyproterone acetate—Sweating—Epirubicin—pancreatic cancer	0.000305	0.000638	CcSEcCtD
Cyproterone acetate—Pollakiuria—Doxorubicin—pancreatic cancer	0.000305	0.000638	CcSEcCtD
Cyproterone acetate—Asthenia—Gemcitabine—pancreatic cancer	0.000304	0.000636	CcSEcCtD
Cyproterone acetate—Haematuria—Epirubicin—pancreatic cancer	0.000303	0.000634	CcSEcCtD
Cyproterone acetate—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000301	0.00063	CcSEcCtD
Cyproterone acetate—AR—Generic Transcription Pathway—NOTCH4—pancreatic cancer	0.000301	0.00243	CbGpPWpGaD
Cyproterone acetate—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000301	0.000629	CcSEcCtD
Cyproterone acetate—Oedema—Docetaxel—pancreatic cancer	0.000301	0.000629	CcSEcCtD
Cyproterone acetate—Weight increased—Doxorubicin—pancreatic cancer	0.0003	0.000628	CcSEcCtD
Cyproterone acetate—Pruritus—Gemcitabine—pancreatic cancer	0.0003	0.000627	CcSEcCtD
Cyproterone acetate—Weight decreased—Doxorubicin—pancreatic cancer	0.000298	0.000625	CcSEcCtD
Cyproterone acetate—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000298	0.000623	CcSEcCtD
Cyproterone acetate—Diarrhoea—Irinotecan—pancreatic cancer	0.000297	0.000623	CcSEcCtD
Cyproterone acetate—Shock—Docetaxel—pancreatic cancer	0.000296	0.000619	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Docetaxel—pancreatic cancer	0.000295	0.000617	CcSEcCtD
Cyproterone acetate—Pruritus—Fluorouracil—pancreatic cancer	0.000295	0.000617	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000294	0.000616	CcSEcCtD
Cyproterone acetate—Tachycardia—Docetaxel—pancreatic cancer	0.000293	0.000614	CcSEcCtD
Cyproterone acetate—Skin disorder—Docetaxel—pancreatic cancer	0.000292	0.000611	CcSEcCtD
Cyproterone acetate—Diarrhoea—Gemcitabine—pancreatic cancer	0.00029	0.000606	CcSEcCtD
Cyproterone acetate—Renal failure—Doxorubicin—pancreatic cancer	0.000289	0.000605	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	0.000289	0.00234	CbGpPWpGaD
Cyproterone acetate—Dizziness—Irinotecan—pancreatic cancer	0.000288	0.000602	CcSEcCtD
Cyproterone acetate—Haemoglobin—Epirubicin—pancreatic cancer	0.000287	0.0006	CcSEcCtD
Cyproterone acetate—Jaundice—Doxorubicin—pancreatic cancer	0.000287	0.0006	CcSEcCtD
Cyproterone acetate—Anorexia—Docetaxel—pancreatic cancer	0.000286	0.0006	CcSEcCtD
Cyproterone acetate—Hepatitis—Epirubicin—pancreatic cancer	0.000285	0.000597	CcSEcCtD
Cyproterone acetate—Haemorrhage—Epirubicin—pancreatic cancer	0.000285	0.000597	CcSEcCtD
Cyproterone acetate—Diarrhoea—Fluorouracil—pancreatic cancer	0.000285	0.000596	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—HIF1A—pancreatic cancer	0.000283	0.00229	CbGpPWpGaD
Cyproterone acetate—Sweating—Doxorubicin—pancreatic cancer	0.000282	0.00059	CcSEcCtD
Cyproterone acetate—Hypotension—Docetaxel—pancreatic cancer	0.000281	0.000588	CcSEcCtD
Cyproterone acetate—Haematuria—Doxorubicin—pancreatic cancer	0.00028	0.000587	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Epirubicin—pancreatic cancer	0.00028	0.000587	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—PPARG—pancreatic cancer	0.000278	0.00225	CbGpPWpGaD
Cyproterone acetate—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000278	0.000582	CcSEcCtD
Cyproterone acetate—AR—Androgen receptor signaling pathway—EGFR—pancreatic cancer	0.000277	0.00224	CbGpPWpGaD
Cyproterone acetate—Vomiting—Irinotecan—pancreatic cancer	0.000276	0.000579	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	0.000276	0.00224	CbGpPWpGaD
Cyproterone acetate—Dizziness—Fluorouracil—pancreatic cancer	0.000275	0.000576	CcSEcCtD
Cyproterone acetate—Visual impairment—Epirubicin—pancreatic cancer	0.000275	0.000576	CcSEcCtD
Cyproterone acetate—Rash—Irinotecan—pancreatic cancer	0.000274	0.000574	CcSEcCtD
Cyproterone acetate—Dermatitis—Irinotecan—pancreatic cancer	0.000274	0.000573	CcSEcCtD
Cyproterone acetate—Headache—Irinotecan—pancreatic cancer	0.000272	0.00057	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Epirubicin—pancreatic cancer	0.00027	0.000565	CcSEcCtD
Cyproterone acetate—Vomiting—Gemcitabine—pancreatic cancer	0.000269	0.000564	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—RB1—pancreatic cancer	0.000268	0.00217	CbGpPWpGaD
Cyproterone acetate—Dyspnoea—Docetaxel—pancreatic cancer	0.000268	0.000561	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CDH1—pancreatic cancer	0.000267	0.00216	CbGpPWpGaD
Cyproterone acetate—Rash—Gemcitabine—pancreatic cancer	0.000267	0.000559	CcSEcCtD
Cyproterone acetate—Dermatitis—Gemcitabine—pancreatic cancer	0.000267	0.000558	CcSEcCtD
Cyproterone acetate—Eye disorder—Epirubicin—pancreatic cancer	0.000267	0.000558	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—RB1—pancreatic cancer	0.000266	0.00216	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—NR5A2—pancreatic cancer	0.000266	0.00215	CbGpPWpGaD
Cyproterone acetate—NR3C1—Endoderm Differentiation—TGFB1—pancreatic cancer	0.000266	0.00215	CbGpPWpGaD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—AKT1—pancreatic cancer	0.000266	0.00215	CbGpPWpGaD
Cyproterone acetate—Haemoglobin—Doxorubicin—pancreatic cancer	0.000265	0.000555	CcSEcCtD
Cyproterone acetate—Headache—Gemcitabine—pancreatic cancer	0.000265	0.000555	CcSEcCtD
Cyproterone acetate—Vomiting—Fluorouracil—pancreatic cancer	0.000265	0.000554	CcSEcCtD
Cyproterone acetate—Dyspepsia—Docetaxel—pancreatic cancer	0.000265	0.000554	CcSEcCtD
Cyproterone acetate—Haemorrhage—Doxorubicin—pancreatic cancer	0.000264	0.000553	CcSEcCtD
Cyproterone acetate—Hepatitis—Doxorubicin—pancreatic cancer	0.000264	0.000553	CcSEcCtD
Cyproterone acetate—Rash—Fluorouracil—pancreatic cancer	0.000263	0.00055	CcSEcCtD
Cyproterone acetate—Dermatitis—Fluorouracil—pancreatic cancer	0.000262	0.000549	CcSEcCtD
Cyproterone acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—pancreatic cancer	0.000262	0.00212	CbGpPWpGaD
Cyproterone acetate—Decreased appetite—Docetaxel—pancreatic cancer	0.000261	0.000547	CcSEcCtD
Cyproterone acetate—Headache—Fluorouracil—pancreatic cancer	0.000261	0.000546	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—MYC—pancreatic cancer	0.00026	0.00211	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—TGFB1—pancreatic cancer	0.00026	0.0021	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000259	0.000543	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000259	0.000543	CcSEcCtD
Cyproterone acetate—Fatigue—Docetaxel—pancreatic cancer	0.000259	0.000542	CcSEcCtD
Cyproterone acetate—Angiopathy—Epirubicin—pancreatic cancer	0.000259	0.000542	CcSEcCtD
Cyproterone acetate—Nausea—Irinotecan—pancreatic cancer	0.000258	0.000541	CcSEcCtD
Cyproterone acetate—Immune system disorder—Epirubicin—pancreatic cancer	0.000258	0.000539	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000257	0.000538	CcSEcCtD
Cyproterone acetate—Constipation—Docetaxel—pancreatic cancer	0.000257	0.000538	CcSEcCtD
Cyproterone acetate—Chills—Epirubicin—pancreatic cancer	0.000256	0.000536	CcSEcCtD
Cyproterone acetate—AR—Generic Transcription Pathway—NOTCH3—pancreatic cancer	0.000256	0.00207	CbGpPWpGaD
Cyproterone acetate—Visual impairment—Doxorubicin—pancreatic cancer	0.000254	0.000533	CcSEcCtD
Cyproterone acetate—Alopecia—Epirubicin—pancreatic cancer	0.000252	0.000528	CcSEcCtD
Cyproterone acetate—Nausea—Gemcitabine—pancreatic cancer	0.000252	0.000527	CcSEcCtD
Cyproterone acetate—Mental disorder—Epirubicin—pancreatic cancer	0.00025	0.000523	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Doxorubicin—pancreatic cancer	0.00025	0.000522	CcSEcCtD
Cyproterone acetate—Malnutrition—Epirubicin—pancreatic cancer	0.000248	0.00052	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Docetaxel—pancreatic cancer	0.000248	0.000518	CcSEcCtD
Cyproterone acetate—Nausea—Fluorouracil—pancreatic cancer	0.000247	0.000518	CcSEcCtD
Cyproterone acetate—Eye disorder—Doxorubicin—pancreatic cancer	0.000247	0.000516	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000246	0.000514	CcSEcCtD
Cyproterone acetate—Tension—Epirubicin—pancreatic cancer	0.000244	0.00051	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—CXCL8—pancreatic cancer	0.000242	0.00196	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—CHD3—pancreatic cancer	0.000241	0.00195	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—MEN1—pancreatic cancer	0.000241	0.00195	CbGpPWpGaD
Cyproterone acetate—Angiopathy—Doxorubicin—pancreatic cancer	0.00024	0.000501	CcSEcCtD
Cyproterone acetate—Immune system disorder—Doxorubicin—pancreatic cancer	0.000238	0.000499	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000238	0.000498	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CASP3—pancreatic cancer	0.000238	0.00192	CbGpPWpGaD
Cyproterone acetate—Abdominal pain—Docetaxel—pancreatic cancer	0.000238	0.000497	CcSEcCtD
Cyproterone acetate—Body temperature increased—Docetaxel—pancreatic cancer	0.000238	0.000497	CcSEcCtD
Cyproterone acetate—Chills—Doxorubicin—pancreatic cancer	0.000237	0.000496	CcSEcCtD
Cyproterone acetate—Alopecia—Doxorubicin—pancreatic cancer	0.000233	0.000488	CcSEcCtD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—pancreatic cancer	0.000232	0.00188	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	0.000232	0.00187	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CCND1—pancreatic cancer	0.000231	0.00187	CbGpPWpGaD
Cyproterone acetate—Mental disorder—Doxorubicin—pancreatic cancer	0.000231	0.000484	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Epirubicin—pancreatic cancer	0.00023	0.000482	CcSEcCtD
Cyproterone acetate—Malnutrition—Doxorubicin—pancreatic cancer	0.00023	0.000481	CcSEcCtD
Cyproterone acetate—Anaemia—Epirubicin—pancreatic cancer	0.00023	0.000481	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CTNNB1—pancreatic cancer	0.000229	0.00185	CbGpPWpGaD
Cyproterone acetate—Agitation—Epirubicin—pancreatic cancer	0.000228	0.000478	CcSEcCtD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—NOTCH4—pancreatic cancer	0.000228	0.00185	CbGpPWpGaD
Cyproterone acetate—Tension—Doxorubicin—pancreatic cancer	0.000226	0.000472	CcSEcCtD
Cyproterone acetate—Malaise—Epirubicin—pancreatic cancer	0.000224	0.000469	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—PTEN—pancreatic cancer	0.000223	0.00181	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	0.000223	0.00181	CbGpPWpGaD
Cyproterone acetate—Syncope—Epirubicin—pancreatic cancer	0.000223	0.000466	CcSEcCtD
Cyproterone acetate—Leukopenia—Epirubicin—pancreatic cancer	0.000222	0.000465	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Docetaxel—pancreatic cancer	0.000221	0.000463	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Epirubicin—pancreatic cancer	0.000218	0.000457	CcSEcCtD
Cyproterone acetate—Cough—Epirubicin—pancreatic cancer	0.000217	0.000454	CcSEcCtD
Cyproterone acetate—Asthenia—Docetaxel—pancreatic cancer	0.000216	0.000451	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—TP53—pancreatic cancer	0.000214	0.00173	CbGpPWpGaD
Cyproterone acetate—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000213	0.000446	CcSEcCtD
Cyproterone acetate—Pruritus—Docetaxel—pancreatic cancer	0.000213	0.000445	CcSEcCtD
Cyproterone acetate—Anaemia—Doxorubicin—pancreatic cancer	0.000212	0.000445	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	0.000212	0.00172	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—pancreatic cancer	0.000212	0.00171	CbGpPWpGaD
Cyproterone acetate—Agitation—Doxorubicin—pancreatic cancer	0.000211	0.000442	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.00021	0.00044	CcSEcCtD
Cyproterone acetate—Discomfort—Epirubicin—pancreatic cancer	0.000209	0.000437	CcSEcCtD
Cyproterone acetate—Malaise—Doxorubicin—pancreatic cancer	0.000207	0.000434	CcSEcCtD
Cyproterone acetate—Syncope—Doxorubicin—pancreatic cancer	0.000206	0.000431	CcSEcCtD
Cyproterone acetate—Leukopenia—Doxorubicin—pancreatic cancer	0.000206	0.000431	CcSEcCtD
Cyproterone acetate—Diarrhoea—Docetaxel—pancreatic cancer	0.000206	0.00043	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CASP3—pancreatic cancer	0.000205	0.00166	CbGpPWpGaD
Cyproterone acetate—Oedema—Epirubicin—pancreatic cancer	0.000203	0.000424	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000202	0.000423	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—NR5A2—pancreatic cancer	0.000202	0.00163	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—VEGFA—pancreatic cancer	0.000202	0.00163	CbGpPWpGaD
Cyproterone acetate—Cough—Doxorubicin—pancreatic cancer	0.000201	0.00042	CcSEcCtD
Cyproterone acetate—Shock—Epirubicin—pancreatic cancer	0.000199	0.000417	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CCND1—pancreatic cancer	0.000199	0.00161	CbGpPWpGaD
Cyproterone acetate—Nervous system disorder—Epirubicin—pancreatic cancer	0.000199	0.000416	CcSEcCtD
Cyproterone acetate—Dizziness—Docetaxel—pancreatic cancer	0.000199	0.000416	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000198	0.000415	CcSEcCtD
Cyproterone acetate—Tachycardia—Epirubicin—pancreatic cancer	0.000198	0.000414	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—pancreatic cancer	0.000197	0.0016	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	0.000197	0.00159	CbGpPWpGaD
Cyproterone acetate—Skin disorder—Epirubicin—pancreatic cancer	0.000197	0.000412	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	0.000196	0.00159	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—AKT1—pancreatic cancer	0.000196	0.00159	CbGpPWpGaD
Cyproterone acetate—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000196	0.00041	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—CTNNB1—pancreatic cancer	0.000196	0.00159	CbGpPWpGaD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000194	0.000407	CcSEcCtD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—NOTCH3—pancreatic cancer	0.000194	0.00157	CbGpPWpGaD
Cyproterone acetate—Discomfort—Doxorubicin—pancreatic cancer	0.000193	0.000405	CcSEcCtD
Cyproterone acetate—Anorexia—Epirubicin—pancreatic cancer	0.000193	0.000404	CcSEcCtD
Cyproterone acetate—AR—Generic Transcription Pathway—SMAD4—pancreatic cancer	0.000193	0.00156	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—PTEN—pancreatic cancer	0.000192	0.00156	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	0.000192	0.00155	CbGpPWpGaD
Cyproterone acetate—Vomiting—Docetaxel—pancreatic cancer	0.000191	0.0004	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	0.00019	0.00154	CbGpPWpGaD
Cyproterone acetate—Rash—Docetaxel—pancreatic cancer	0.00019	0.000397	CcSEcCtD
Cyproterone acetate—Hypotension—Epirubicin—pancreatic cancer	0.000189	0.000396	CcSEcCtD
Cyproterone acetate—Dermatitis—Docetaxel—pancreatic cancer	0.000189	0.000396	CcSEcCtD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—TP53—pancreatic cancer	0.000188	0.00153	CbGpPWpGaD
Cyproterone acetate—Headache—Docetaxel—pancreatic cancer	0.000188	0.000394	CcSEcCtD
Cyproterone acetate—Oedema—Doxorubicin—pancreatic cancer	0.000188	0.000393	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—MYC—pancreatic cancer	0.000186	0.0015	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	0.000185	0.0015	CbGpPWpGaD
Cyproterone acetate—Shock—Doxorubicin—pancreatic cancer	0.000185	0.000386	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000184	0.000385	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000184	0.000384	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CXCL8—pancreatic cancer	0.000184	0.00149	CbGpPWpGaD
Cyproterone acetate—Tachycardia—Doxorubicin—pancreatic cancer	0.000183	0.000383	CcSEcCtD
Cyproterone acetate—Skin disorder—Doxorubicin—pancreatic cancer	0.000182	0.000381	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—EGFR—pancreatic cancer	0.000181	0.00147	CbGpPWpGaD
Cyproterone acetate—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000181	0.00038	CcSEcCtD
Cyproterone acetate—Dyspnoea—Epirubicin—pancreatic cancer	0.000181	0.000378	CcSEcCtD
Cyproterone acetate—Anorexia—Doxorubicin—pancreatic cancer	0.000179	0.000374	CcSEcCtD
Cyproterone acetate—Nausea—Docetaxel—pancreatic cancer	0.000179	0.000374	CcSEcCtD
Cyproterone acetate—Dyspepsia—Epirubicin—pancreatic cancer	0.000178	0.000373	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—PRSS1—pancreatic cancer	0.000178	0.00144	CbGpPWpGaD
Cyproterone acetate—Decreased appetite—Epirubicin—pancreatic cancer	0.000176	0.000369	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	0.000176	0.00142	CbGpPWpGaD
Cyproterone acetate—Hypotension—Doxorubicin—pancreatic cancer	0.000175	0.000367	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000175	0.000366	CcSEcCtD
Cyproterone acetate—Fatigue—Epirubicin—pancreatic cancer	0.000175	0.000366	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—pancreatic cancer	0.000174	0.0014	CbGpPWpGaD
Cyproterone acetate—Constipation—Epirubicin—pancreatic cancer	0.000173	0.000363	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	0.000172	0.00139	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—KRAS—pancreatic cancer	0.000171	0.00139	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—STAT3—pancreatic cancer	0.000171	0.00138	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	0.000169	0.00137	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—TNF—pancreatic cancer	0.000168	0.00136	CbGpPWpGaD
Cyproterone acetate—Dyspnoea—Doxorubicin—pancreatic cancer	0.000167	0.00035	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	0.000167	0.00135	CbGpPWpGaD
Cyproterone acetate—Feeling abnormal—Epirubicin—pancreatic cancer	0.000167	0.00035	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000166	0.000347	CcSEcCtD
Cyproterone acetate—Dyspepsia—Doxorubicin—pancreatic cancer	0.000165	0.000346	CcSEcCtD
Cyproterone acetate—Decreased appetite—Doxorubicin—pancreatic cancer	0.000163	0.000341	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000162	0.000339	CcSEcCtD
Cyproterone acetate—Fatigue—Doxorubicin—pancreatic cancer	0.000162	0.000338	CcSEcCtD
Cyproterone acetate—Urticaria—Epirubicin—pancreatic cancer	0.000161	0.000337	CcSEcCtD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—pancreatic cancer	0.000161	0.0013	CbGpPWpGaD
Cyproterone acetate—Constipation—Doxorubicin—pancreatic cancer	0.00016	0.000336	CcSEcCtD
Cyproterone acetate—Body temperature increased—Epirubicin—pancreatic cancer	0.00016	0.000335	CcSEcCtD
Cyproterone acetate—Abdominal pain—Epirubicin—pancreatic cancer	0.00016	0.000335	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—MYC—pancreatic cancer	0.00016	0.00129	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—AKT1—pancreatic cancer	0.000159	0.00129	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—TGFB1—pancreatic cancer	0.000158	0.00128	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—EGFR—pancreatic cancer	0.000156	0.00126	CbGpPWpGaD
Cyproterone acetate—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000155	0.000324	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—ARG2—pancreatic cancer	0.000154	0.00125	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	0.000154	0.00124	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	0.000153	0.00124	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000153	0.000321	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—MEN1—pancreatic cancer	0.000153	0.00124	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—TP53—pancreatic cancer	0.000152	0.00123	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	0.00015	0.00122	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Epirubicin—pancreatic cancer	0.000149	0.000313	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	0.000149	0.00121	CbGpPWpGaD
Cyproterone acetate—Urticaria—Doxorubicin—pancreatic cancer	0.000149	0.000312	CcSEcCtD
Cyproterone acetate—Abdominal pain—Doxorubicin—pancreatic cancer	0.000148	0.00031	CcSEcCtD
Cyproterone acetate—Body temperature increased—Doxorubicin—pancreatic cancer	0.000148	0.00031	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—TNF—pancreatic cancer	0.000148	0.0012	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—KRAS—pancreatic cancer	0.000148	0.00119	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—SMAD4—pancreatic cancer	0.000146	0.00118	CbGpPWpGaD
Cyproterone acetate—Asthenia—Epirubicin—pancreatic cancer	0.000145	0.000304	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—NOTCH4—pancreatic cancer	0.000145	0.00117	CbGpPWpGaD
Cyproterone acetate—Pruritus—Epirubicin—pancreatic cancer	0.000143	0.0003	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	0.000143	0.00116	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	0.000142	0.00115	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—NOTCH1—pancreatic cancer	0.000142	0.00115	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Epirubicin—pancreatic cancer	0.000139	0.00029	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000138	0.000289	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—HSPA1B—pancreatic cancer	0.000138	0.00112	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—TYMP—pancreatic cancer	0.000135	0.00109	CbGpPWpGaD
Cyproterone acetate—Asthenia—Doxorubicin—pancreatic cancer	0.000135	0.000282	CcSEcCtD
Cyproterone acetate—Dizziness—Epirubicin—pancreatic cancer	0.000134	0.000281	CcSEcCtD
Cyproterone acetate—AR—Generic Transcription Pathway—PPARG—pancreatic cancer	0.000134	0.00108	CbGpPWpGaD
Cyproterone acetate—Pruritus—Doxorubicin—pancreatic cancer	0.000133	0.000278	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—TP53—pancreatic cancer	0.000131	0.00106	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	0.000131	0.00106	CbGpPWpGaD
Cyproterone acetate—Vomiting—Epirubicin—pancreatic cancer	0.000129	0.00027	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—AKT1—pancreatic cancer	0.000129	0.00104	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Doxorubicin—pancreatic cancer	0.000128	0.000269	CcSEcCtD
Cyproterone acetate—Rash—Epirubicin—pancreatic cancer	0.000128	0.000268	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—TNF—pancreatic cancer	0.000128	0.00103	CbGpPWpGaD
Cyproterone acetate—Dermatitis—Epirubicin—pancreatic cancer	0.000128	0.000267	CcSEcCtD
Cyproterone acetate—Headache—Epirubicin—pancreatic cancer	0.000127	0.000266	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	0.000126	0.00102	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—EZH2—pancreatic cancer	0.000126	0.00102	CbGpPWpGaD
Cyproterone acetate—Dizziness—Doxorubicin—pancreatic cancer	0.000124	0.00026	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—NOTCH3—pancreatic cancer	0.000123	0.000996	CbGpPWpGaD
Cyproterone acetate—Nausea—Epirubicin—pancreatic cancer	0.00012	0.000252	CcSEcCtD
Cyproterone acetate—Vomiting—Doxorubicin—pancreatic cancer	0.000119	0.00025	CcSEcCtD
Cyproterone acetate—Rash—Doxorubicin—pancreatic cancer	0.000118	0.000248	CcSEcCtD
Cyproterone acetate—Dermatitis—Doxorubicin—pancreatic cancer	0.000118	0.000247	CcSEcCtD
Cyproterone acetate—Headache—Doxorubicin—pancreatic cancer	0.000118	0.000246	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—HSPA1A—pancreatic cancer	0.000117	0.000944	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—MEN1—pancreatic cancer	0.000116	0.000938	CbGpPWpGaD
Cyproterone acetate—Nausea—Doxorubicin—pancreatic cancer	0.000111	0.000233	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	0.000111	0.000901	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—AKT1—pancreatic cancer	0.000111	0.000896	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—NOTCH4—pancreatic cancer	0.00011	0.000889	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GLP1R—pancreatic cancer	0.000109	0.00088	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—NOTCH1—pancreatic cancer	0.000108	0.000872	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—DPYD—pancreatic cancer	0.000107	0.000865	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	0.000107	0.000863	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—HSPA1B—pancreatic cancer	0.000105	0.000848	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—PPARG—pancreatic cancer	0.000102	0.000823	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SLC2A2—pancreatic cancer	0.000101	0.000821	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	0.0001	0.000813	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	9.69e-05	0.000784	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—EZH2—pancreatic cancer	9.54e-05	0.000772	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—NOTCH3—pancreatic cancer	9.34e-05	0.000756	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—SMAD4—pancreatic cancer	9.27e-05	0.00075	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—HSPA1A—pancreatic cancer	8.84e-05	0.000716	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	8.83e-05	0.000714	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CD44—pancreatic cancer	7.86e-05	0.000636	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	7.69e-05	0.000623	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—MYC—pancreatic cancer	7.64e-05	0.000618	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	7.62e-05	0.000617	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GCG—pancreatic cancer	7.53e-05	0.00061	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—STK11—pancreatic cancer	7.08e-05	0.000573	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—SMAD4—pancreatic cancer	7.03e-05	0.000569	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—NOTCH1—pancreatic cancer	6.83e-05	0.000553	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	6.65e-05	0.000538	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—PPARG—pancreatic cancer	6.45e-05	0.000522	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—TYMS—pancreatic cancer	6.09e-05	0.000493	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—MYC—pancreatic cancer	5.79e-05	0.000469	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—NOTCH1—pancreatic cancer	5.18e-05	0.00042	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—APOE—pancreatic cancer	4.95e-05	0.000401	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—PPARG—pancreatic cancer	4.89e-05	0.000396	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.69e-05	0.00038	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3CG—pancreatic cancer	4.47e-05	0.000362	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PPARG—pancreatic cancer	4.32e-05	0.000349	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3CD—pancreatic cancer	3.93e-05	0.000318	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—MYC—pancreatic cancer	3.68e-05	0.000298	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3CB—pancreatic cancer	3.43e-05	0.000277	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PTGS2—pancreatic cancer	3.39e-05	0.000275	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PTEN—pancreatic cancer	2.96e-05	0.00024	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—MYC—pancreatic cancer	2.79e-05	0.000226	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—AKT1—pancreatic cancer	2.55e-05	0.000206	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3CA—pancreatic cancer	2.09e-05	0.000169	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—AKT1—pancreatic cancer	1.93e-05	0.000157	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—AKT1—pancreatic cancer	1.71e-05	0.000138	CbGpPWpGaD
